Currently available evidence does not support the recent "Hour-1 Bundle" recommendation to perform five initial treatment steps within the first hour in patients with sepsis. That's the position of the European Society of Emergency Medicine (EUSEM), published in the May/June issue of the European Journal of Emergency Medicine, official journal of EUSEM. The journal is published in the Lippincott portfolio by Wolters Kluwer.
While acknowledging the importance of early recognition and treatment of sepsis, "The EUSEM wishes to express its concerns regarding the low level of evidence that underlies these guidances, and potential implication from an emergency physician point of view," according to the position paper by a panel of leading European emergency medicine specialists. The lead author is Prof. Yonathan Freund of Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris.
Concerns about 'unexpected harm' from updated sepsis recommendations
In 2018, the Surviving Sepsis Campaign (SSC) issued an updated set of recommendations for initial treatment of sepsis and septic shock. The SSC is a global cooperative effort to improve treatment and reduce the risk of death from sepsis. Sepsis is a common and potentially life-threatening condition, occurring when the immune system mounts an overwhelming inflammatory response to infection.
The 2018 update introduced an "Hour-1 Bundle" of steps that healthcare professionals should begin as soon as time of triage: measuring blood lactate level, performing blood cultures, and starting treatment with antibiotics, intravenous fluids, and vasopressors if indicated.
The recommendation to perform these five steps within the first hour represents an acceleration of treatment, compared to the 3-hour target recommended in the 2016 SSC guidelines. Even the definition of "time zero" moved forward: from the time of sepsis recognition to the time of triage in the emergency department.
The new EUSEM position paper is an "expression of concern" over the updated recommendations. Noting the prominent role of emergency physicians in initial recognition and care of patients with sepsis, the EUSEM position paper highlights the low to moderate quality of evidence supporting the Hour-1 Bundle. "The empirical basis for the reduced timeframe of the sepsis bundle is too weak to be mandatory," Prof. Freund and coauthors write.
The authors note deficiencies in other recommendations as well, raising questions about the benefits of early lactate measurement and intravenous fluids. Rather, they conclude, starting antibiotics as soon as the likely diagnosis of sepsis is made seems to be the key factor responsible for the improvement in outcomes with early treatment.
The EUSEM statement questions whether it is practical to start all elements of the sepsis bundle within the first hour – especially since up to one in five patients initially diagnosed with sepsis are ultimately found to have a noninfectious diagnosis. Prof. Freund and colleagues also express concern about possible unintended consequences of setting the "Hour-1 Bundle" as the standard of care. They write, "In emergency medicine, unrealistic time targets taken as quality indicators may cause unexpected harm."
Completion of the sepsis bundle within one hour after triage is not evidence based and may even be potentially harmful. Therefore, EUSEM cannot support the new SSC guidance, but emphasizes the early recognition of sepsis and timely administration of antibiotics in appropriately selected patients within 1 hour of triage."
Prof. Yonathan Freund and coauthors
Source:
Wolters Kluwer
Journal reference:
Freund, Y. et al. (2019) European Society of Emergency Medicine position paper on the 1-hour sepsis bundle of the Surviving Sepsis Campaign. European Journal of Emergency Medicine. doi.org/10.1097/MEJ.0000000000000603.
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare